Mobarak, Ahmed Mushfiq, Edward Miguel, Jason Abaluck, Amrita Ahuja, Marcella Alsan, Abhijit Banerjee, Emily Breza, Arun G. Chandrasekhar, Esther Duflo, James Dzansi, Denise Garrett, Paul Goldsmith-Pinkham, Gregg S. Gonsalves, Muhammad Masqud Hossain, Aleksandra Jakubowski, Gagandeep Kang, Arjun Kharel, Michael Kremer, Niccolo Meriggi, Carol Nekesa, Benjamin A. Olken, Saad B. Omer, Firdausi Qadri, Helen Rees, Babatunde Salako, Maarten Voors, Shana Warren, Witold Wiecek. (2022). “End COVID-19 in low- and middle-income countries”, Science, 375(6586), doi: 10.1126/science.abo4089
Vaccines are changing the course of the COVID-19 pandemic, but in grossly uneven ways. Low- and middle-income countries (LMICs) face considerable obstacles in both receiving and distributing doses. To limit virus transmission, its devastating impacts, and opportunities for further mutations, this must change. Until it does, nonpharmaceutical interventions such as masking must remain a priority. Science invited global experts to highlight research and innovations aimed at quickening the end of COVID-19 in LMICs.